SCH 486757
DrugSCH 486757 2 x 50-mg capsule twice daily orally for 2 weeks followed by a 2-week washout period and 2 weeks of crossover treatment
NCT Number: NCT00506987
This is a randomized, double-blind, placebo-controlled, crossover, single center study of SCH 486757 in subjects with chronic cough. Subjects will be randomized to receive SCH 486757 or placebo for 14 days. After a 2-week washout period, subjects will be crossed over to the other treatment. The primary objective is to evaluate the effectiveness of SCH 486757 in reducing cough reflex sensitivity as determined by a challenge with capsaicin, an agent that induces cough.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 2
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
SCH 486757 2 x 50-mg capsule twice daily orally for 2 weeks followed by a 2-week washout period and 2 weeks of crossover treatment
Matching placebo capsules twice daily orally for 2 weeks followed by a 2 week washout period and 2 weeks of crossover treatment
Time frame: After 2 weeks of treatment.
Time frame: After 2 weeks of treatment.
Merck Sharp & Dohme LLC
Industry
Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Idiopathic Cough
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05599191
Chronic Cough, Cough
Jasper, Alabama, United States
View Trial DetailsNCT06716645
Common Cold, Cough
New York, United States
View Trial DetailsNCT07420491
Cough, Pathological Conditions, Signs and Symptoms
Jakarta, Jakarta Special Capital Region, Indonesia
View Trial DetailsNCT05888350
Chronic Cough, Cough
Guangzhou, Guangdong, China
View Trial Details